Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.70
-0.20 (-2.90%)
Sep 29, 2026, 1:28 PM EDT - Market open
Kyntra Bio Market Cap
Kyntra Bio has a market cap or net worth of $27.13 million as of September 29, 2026. Its market cap has decreased by -45.52% in one year.
Market Cap
27.13M
Enterprise Value
-64.19M
1-Year Change
-45.52%
Ranking
Category
Stock Price
$6.70
ChartMarket Cap Chart
Since November 14, 2014, Kyntra Bio's market cap has decreased from $1.22B to $27.13M, a decrease of -97.79%. That is a compound annual growth rate of -27.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 27.13M | -23.58% |
| Dec 31, 2025 | 35.50M | -33.52% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
| Nov 14, 2014 | 1.22B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 29.98M |
| CEL-SCI | 29.90M |
| Quince Therapeutics | 29.49M |
| aTyr Pharma | 29.20M |
| TransCode Therapeutics | 28.95M |
| IGC Pharma | 28.33M |
| CDT Equity | 27.25M |
| ABVC BioPharma | 27.22M |